Impact of choice of treatment for bleeding episodes on inhibitor outcome in patients with mild/moderate hemophilia A and inhibitors
- Author
- D'OIRON, Roseline1 2 ; VOLOT, F3 ; MARQUES-VERDIER, A; LIENHART, A; BERTHIER, A. M; MOREAU, P; LAMBERT, T1 ; REYNAUD, J4 ; PEERLINCK, K2 ; GOUDEMAND, J; GUEROIS, C; ROTHSCHILD, C; CHAMBOST, H; BOREL-DERLON, A; ROUSSEL-ROBERT, V
MHAI Study Group, France
[1] Hemophilia Center, APHP Bicetre University Hospital, Le Kremlin-Bicetre, France
[2] Center for Molecular and Vascular Biology, University of Leuven, Leuven, Belgium
[3] Hemophilia Centers-University Hospital of Dijon, France
[4] Hemophilia Centers-University Hospital of St-Etienne, France - Conference name
- Novo Nordisk Symposium on Haemostasis Management (8 ; Copenhagen 2005-05-11)
- Source
Seminars in hematology. 2006, Vol 43, Num 1, pp S3-S9 ; SUP1 ; ref : 45 ref
- CODEN
- SEHEA3
- ISSN
- 0037-1963
- Scientific domain
- Hematology
- Publisher
- Elsevier, New York, NY
- Publication country
- United States
- Document type
- Conference Paper
- Language
- English
- Keyword (fr)
- Choix Homme Hématologie Hémophilie A Hémorragie Inhibiteur Pronostic Traitement Coagulopathie Hémopathie Maladie héréditaire
- Keyword (en)
- Choice Human Hematology Hemophilia A Hemorrhage Inhibitor Prognosis Treatment Coagulopathy Hemopathy Genetic disease
- Keyword (es)
- Elección Hombre Hematología Hemofilia A Hemorragia Inhibidor Pronóstico Tratamiento Coagulopatía Hemopatía Enfermedad hereditaria
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19C Platelet diseases and coagulopathies
- Discipline
- Blood diseases
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 17483236
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1053/j.seminhematol.2005.11.002 
https://dx.doi.org/10.1053/j.seminhematol.2005.11.002
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1053\/j.seminhematol.2005.11.002\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:131:\"Impact of choice of treatment for bleeding episodes on inhibitor outcome in patients with mild\/moderate hemophilia A and inhibitors\";s:9:\"\u0000*\u0000jtitle\";s:22:\"Seminars in hematology\";s:9:\"\u0000*\u0000stitle\";s:14:\"Semin. hematol\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"43\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"S3\";s:8:\"\u0000*\u0000epage\";s:2:\"S9\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0037-1963\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"D'OIRON\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Roseline\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:8:\"VOLOT, F\";i:1;s:18:\"MARQUES-VERDIER, A\";i:2;s:11:\"LIENHART, A\";i:3;s:14:\"BERTHIER, A. M\";i:4;s:9:\"MOREAU, P\";i:5;s:10:\"LAMBERT, T\";i:6;s:10:\"REYNAUD, J\";i:7;s:12:\"PEERLINCK, K\";i:8;s:12:\"GOUDEMAND, J\";i:9;s:10:\"GUEROIS, C\";i:10;s:13:\"ROTHSCHILD, C\";i:11;s:11:\"CHAMBOST, H\";i:12;s:15:\"BOREL-DERLON, A\";i:13;s:17:\"ROUSSEL-ROBERT, V\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"SEHEA3\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:4:\"SUP1\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:131:\"Impact of choice of treatment for bleeding episodes on inhibitor outcome in patients with mild\/moderate hemophilia A and inhibitors\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1053\/j.seminhematol.2005.11.002\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:131:\"Impact of choice of treatment for bleeding episodes on inhibitor outcome in patients with mild\/moderate hemophilia A and inhibitors\";s:9:\"\u0000*\u0000jtitle\";s:22:\"Seminars in hematology\";s:9:\"\u0000*\u0000stitle\";s:14:\"Semin. hematol\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"43\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"S3\";s:8:\"\u0000*\u0000epage\";s:2:\"S9\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0037-1963\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"D'OIRON\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Roseline\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:8:\"VOLOT, F\";i:1;s:18:\"MARQUES-VERDIER, A\";i:2;s:11:\"LIENHART, A\";i:3;s:14:\"BERTHIER, A. M\";i:4;s:9:\"MOREAU, P\";i:5;s:10:\"LAMBERT, T\";i:6;s:10:\"REYNAUD, J\";i:7;s:12:\"PEERLINCK, K\";i:8;s:12:\"GOUDEMAND, J\";i:9;s:10:\"GUEROIS, C\";i:10;s:13:\"ROTHSCHILD, C\";i:11;s:11:\"CHAMBOST, H\";i:12;s:15:\"BOREL-DERLON, A\";i:13;s:17:\"ROUSSEL-ROBERT, V\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"SEHEA3\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:4:\"SUP1\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:131:\"Impact of choice of treatment for bleeding episodes on inhibitor outcome in patients with mild\/moderate hemophilia A and inhibitors\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:34:\"10.1053\/j.seminhematol.2005.11.002\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1053\/j.seminhematol.2005.11.002\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:131:\"Impact of choice of treatment for bleeding episodes on inhibitor outcome in patients with mild\/moderate hemophilia A and inhibitors\";s:9:\"\u0000*\u0000jtitle\";s:22:\"Seminars in hematology\";s:9:\"\u0000*\u0000stitle\";s:14:\"Semin. hematol\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"43\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"S3\";s:8:\"\u0000*\u0000epage\";s:2:\"S9\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0037-1963\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"D'OIRON\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Roseline\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:8:\"VOLOT, F\";i:1;s:18:\"MARQUES-VERDIER, A\";i:2;s:11:\"LIENHART, A\";i:3;s:14:\"BERTHIER, A. M\";i:4;s:9:\"MOREAU, P\";i:5;s:10:\"LAMBERT, T\";i:6;s:10:\"REYNAUD, J\";i:7;s:12:\"PEERLINCK, K\";i:8;s:12:\"GOUDEMAND, J\";i:9;s:10:\"GUEROIS, C\";i:10;s:13:\"ROTHSCHILD, C\";i:11;s:11:\"CHAMBOST, H\";i:12;s:15:\"BOREL-DERLON, A\";i:13;s:17:\"ROUSSEL-ROBERT, V\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"SEHEA3\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:4:\"SUP1\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:131:\"Impact of choice of treatment for bleeding episodes on inhibitor outcome in patients with mild\/moderate hemophilia A and inhibitors\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:10:\"proceeding\";s:6:\"\u0000*\u0000doi\";s:34:\"10.1053\/j.seminhematol.2005.11.002\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:131:\"Impact of choice of treatment for bleeding episodes on inhibitor outcome in patients with mild\/moderate hemophilia A and inhibitors\";s:9:\"\u0000*\u0000jtitle\";s:22:\"Seminars in hematology\";s:9:\"\u0000*\u0000stitle\";s:14:\"Semin. hematol\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:2:\"43\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"S3\";s:8:\"\u0000*\u0000epage\";s:2:\"S9\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0037-1963\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"D'OIRON\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Roseline\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:14:{i:0;s:8:\"VOLOT, F\";i:1;s:18:\"MARQUES-VERDIER, A\";i:2;s:11:\"LIENHART, A\";i:3;s:14:\"BERTHIER, A. M\";i:4;s:9:\"MOREAU, P\";i:5;s:10:\"LAMBERT, T\";i:6;s:10:\"REYNAUD, J\";i:7;s:12:\"PEERLINCK, K\";i:8;s:12:\"GOUDEMAND, J\";i:9;s:10:\"GUEROIS, C\";i:10;s:13:\"ROTHSCHILD, C\";i:11;s:11:\"CHAMBOST, H\";i:12;s:15:\"BOREL-DERLON, A\";i:13;s:17:\"ROUSSEL-ROBERT, V\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"SEHEA3\";s:8:\"\u0000*\u0000genre\";s:10:\"proceeding\";s:7:\"\u0000*\u0000part\";s:4:\"SUP1\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:131:\"Impact of choice of treatment for bleeding episodes on inhibitor outcome in patients with mild\/moderate hemophilia A and inhibitors\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
